Australian scientists say they’ve found a new immunotherapy that’s showing promise as a treatment for multiple sclerosis.
The therapy is based on a treatment for Epstein-Barr virus.
The connection between Epstein-Barr and multiple sclerosis (MS) was made more than 40 years ago. Recent scientific research continues to show a correlation.
At times, researchers have suggested that a vaccine for Epstein-Barr could be an answer to MS.
This potential new treatment is based on the theory of Dr. Michael Pender, a professor at The University of Queensland and the Royal Brisbane and Women’s Hospital in Australia.
Pender unveiled a new theory in 2003 that MS is caused by an accumulation of cells in the brain infected by Epstein-Barr and that a therapy targeting the virus could potentially stop the progression of MS.
“(Epstein-Barr) affects B cells and once affected, never leaves these B cells,” Pender told Healthline. “In healthy people, the immune system works all the time keeping the virus under control by using T cells.”
from Latest News - SUCH TV https://ift.tt/2SDMHFc
0 comments: